Medical Microbiology articles for Switzerland

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 56

Article ‘Count’ for Medical Microbiology.

Journal Count Share
2 0.50
A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum 0.47
The ATM Kinase Inhibitor AZD0156 Is a Potent Inhibitor of iPlasmodium/i Phosphatidylinositol 4‐Kinase (PI4Kβ) and Is an Attractive Candidate for Medicinal Chemistry Optimization Against Malaria 0.03
1 0.18
The Incubation Periods of Mpox Virus Clade Ib. 0.18
1 0.31
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 0.31
1 0.11
Naturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes 0.11
1 1.00
Impact of Discontinuation of Contact Precautions on Healthcare-associated ESBL-producing Escherichia coli in a Large Tertiary Care Hospital: An Interrupted Time-series Analysis 1.00
1 1.00
Antimicrobial resistance in wildlife: Associations with environmental factors and taxonomic variation 1.00
1 0.06
Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold 0.06
1 0.25
Pharmacological targeting of the mycothiol cysteine ligase MshC in Mycobacterium abscessus 0.25
2 1.25
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains 0.43
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design 0.81
1 0.31
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells 0.31
3 1.47
Anti-spike IgG Avidity Enhances Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2: A Prospective Study of Primary Infections and Immunizations 0.05
Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study 1.00
Diagnostic Performance and Kinetics of Hepatitis E Viral RNA and IgM Antibody Test Positivity in a Genotype 1 Outbreak in South Sudan 0.42
2 1.08
Photoswitchable RNA Degraders for Spatiotemporal Activation of Host-Directed Antivirals in Mammalian Cells 1.00
Targeting the SARS-CoV-2 RNA Translation Initiation Element SL1 by Molecules of Low Molecular Weight 0.08
5 1.03
Host control of persistent Epstein–Barr virus infection 0.00
Pre-assembly of biomolecular condensate seeds drives RSV replication 0.12
Potent neutralization of Marburg virus by a vaccine-elicited antibody 0.35
EBV induces CNS homing of B cells attracting inflammatory T cells 0.53
In vivo screen of Plasmodium targets for mosquito-based malaria control 0.04
18 9.41
Stepwise firing mechanism of an extracellular contractile injection system 1.00
Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis 0.17
B cell immunity to the Lassa virus glycoprotein is a correlate of vaccination-induced virus control in mice 0.88
Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance 0.03
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum 0.03
Identification and structural characterization of anthrax toxin receptor 2 as the Clostridium perfringens NetF receptor 1.00
Efficacy of two rounds of albendazole treatment on soil-transmitted helminths in schoolchildren, Yunnan Province, China 0.06
Segmented filamentous bacteria undergo a structural transition at their adhesive tip during unicellular to filament development 0.20
LANA-specific CD4+ effector T cells accumulate at the site of KSHV infection in humanized mice 0.82
Mechanisms of Pseudomonas aeruginosa resistance to type VI secretion system attacks 1.00
CarbaDetector: a machine learning model for detecting carbapenemase-producing Enterobacterales from disk diffusion tests 0.22
Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis 0.07
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant infection in vivo 0.61
Genome-wide antibiotic-CRISPRi profiling identifies LiaR activation as a strategy to resensitize fluoroquinolone-resistant 1.00
Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR 0.18
CRISPRi screen identifies FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa 0.13
Monkeypox virus spreads from cell-to-cell and leads to neuronal death in human neural organoids 1.00
Structures of the Escherichia coli type 1 pilus during pilus rod assembly and after assembly termination 1.00
1 0.03
Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update 0.03
1 0.08
TMPRSS2-mediated coronavirus spike activation and inhibition 0.08
1 0.04
Livestock antimicrobial use embodied in global supply chains 0.04
2 0.81
Computational design of an ultrapotent deltacoronavirus miniprotein inhibitor 0.27
A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin 0.53
2 0.58
Dynamic shift in the dominant transmission route of clade Ib monkeypox virus across networks with sexual and nonsexual contacts 0.13
A pan-respiratory virus attachment inhibitor with high potency in human airway models and in vivo 0.45
2 0.10
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions 0.03
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum 0.07
1 0.01
Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis 0.01
1 0.57
Thermophilic bacteria employ a contractile injection system in hot spring microbial mats 0.57
2 0.22
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial 0.16
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study 0.05
1 0.04
Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study 0.04
2 0.36
Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical Responses 0.06
Corynebacterium diphtheriae Outbreak in Migrant Populations in Europe 0.30

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.